Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention.
OBJECTIVE
To compare the demographic characteristics and risk behaviors for hepatitis B infection among injection drug users younger than 30 years with those aged 30 or older and to evaluate participants' knowledge, attitudes, and experiences of infection, screening, and vaccination against hepatitis B virus.


METHODS
A systematic sample of injection drug users not currently in a treatment program were recruited and interviewed at needle exchange programs and community sites.


METHODS
135 injection drug users younger than 30 years and 96 injection drug users aged 30 or older.


RESULTS
Injection drug users younger than 30 were twice as likely as drug users aged 30 or older to report having shared needles in the past 30 days (36/135 [27%] vs 12/96 [13%]). Injection drug users younger than 30 were also twice as likely to report having had more than two sexual partners in the past 6 months (80/135 [59%] vs 29/96 [30%]). Although 88 of 135 (68%) young injection drug users reported having had contact with medical providers within the past 6 months only 13 of 135 (10%) had completed the hepatitis B vaccine series and only 16 of (13%) perceived themselves as being at high risk of becoming infected with the virus.


CONCLUSIONS
Few young injection drug users have been immunized even though they have more frequent contact with medical providers and are at a higher risk for new hepatitis B infection than older drug users. Clinicians caring for young injection drug users and others at high risk of infection should provide education, screening, and vaccination to reduce an important source of hepatitis B infection.
Seal
K H
KH
Urban Health Study, UCSF, San Francisco, CA 94110, USA. karene@itsa.ucsf.edu
Ochoa
K C
KC
Hahn
J A
JA
Tulsky
J P
JP
Edlin
B R
BR
Moss
A R
AR
D000328:Adult; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D008297:Male; D012309:Risk-Taking; D012495:San Francisco; D015819:Substance Abuse, Intravenous / Q000150:complications*